This is despite a peer-reviewed paper published in the journal Clinical Infectious Diseases in June finding ivermectin is “ not a viable option to treat COVID-19 patients”. The Elgazzar study was one of the the largest and most promising showing the drug may help Covid patients, and has often been cited by proponents of the drug as evidence of its effectiveness. In the UK, the University of Oxford is testing whether giving people with Covid-19 ivermectin prevents them ending up in hospital. Other studies on ivermectin are still under way. There are signs that they have tried to change one or two fields to make them look more natural.” “It’s certainly the hardest to explain away as innocent error, especially since the clones aren’t even pure copies. “The main error is that at least 79 of the patient records are obvious clones of other records,” Brown told the Guardian. According to his findings the authors had clearly repeated data between patients. Lawrence contacted an Australian chronic disease epidemiologist from the University of Wollongong, Gideon Meyerowitz-Katz, and a data analyst affiliated with Linnaeus University in Sweden who reviews scientific papers for errors, Nick Brown, for help analysing the data and study results more thoroughly.īrown created a comprehensive document uncovering numerous data errors, discrepancies and concerns, which he provided to the Guardian. The university’s press office also did not respond. Lawrence and the Guardian sent Elgazzar a comprehensive list of questions about the data, but did not receive a reply. In their ivermectin treatment group for severe Covid-19, the authors claim two patients died, but the number in their raw data is four.” “According to the original data, the number was 0, the same as the ivermectin treatment group. “In their paper, the authors claim that four out of 100 patients died in their standard treatment group for mild and moderate Covid-19,” Lawrence said.

The data was also terribly formatted, and includes one patient who left hospital on the non-existent date of. “The authors claimed they conducted the study between the 8th of June and 20th of September 2020, however most of the patients who died were admitted into hospital and died before the 8th of June according to the raw data. “The authors claimed to have done the study only on 18-80 year olds, but at least three patients in the dataset were under 18,” Lawrence said. The data also looked suspicious to Lawrence, with the raw data apparently contradicting the study protocol on several occasions. “Humorously, this led to them changing ‘severe acute respiratory syndrome’ to ‘extreme intense respiratory syndrome’ on one occasion,” Lawrence said. It appeared that the authors had run entire paragraphs from press releases and websites about ivermectin and Covid-19 through a thesaurus to change key words. He found the introduction section of the paper appeared to have been almost entirely plagiarised. He first became aware of the Elgazzar preprint when it was assigned to him by one of his lecturers for an assignment that formed part of his master’s degree. Research Square did not outline what those concerns were.Ī medical student in London, Jack Lawrence, was among the first to identify serious concerns about the paper, leading to the retraction. When she's not writing or photographing, Linze enjoys gardening, spending time with her husband and pets, cooking, baking, and grilling, and relaxing with trashy TV.The study found that patients with Covid-19 treated in hospital who “received ivermectin early reported substantial recovery” and that there was “a substantial improvement and reduction in mortality rate in ivermectin treated groups” by 90%.īut the drug’s promise as a treatment for the virus is in serious doubt after the Elgazzar study was pulled from the Research Square website on Thursday “due to ethical concerns”. Her favorite destinations in Illinois include Starved Rock State Park, Chicago's Edgewater neighborhood, the charming small town of Sycamore, and historic Rosehill Cemetery. Whether it's writing about a local gem or world-renowned establishment, Linze brings a heartwarming and historical perspective to each story, using facts, wit, and personal experience to impress upon readers the importance of culture, food, travel, and all things local. She has interviewed Dolly Parton, written about beloved diners along historic Route 66, visited the last Rainforest Cafe in the Illinois, and reviewed luxurious English manor-inspired hotels. Since 2014, her bylines and photography have appeared in the Chicago Tribune, Chicago Magazine, Chicago Sun-Times, and Block Club Chicago/DNAinfo Chicago, Only in Your State, and more. Ope! From the rural cornfields of DeKalb County, Linze is an Illinois native and true Midwestern gal who can make a mean bonfire and whip up a perfect marshmallow salad.

Facebook epic deli